Platelet α-granules: Basic biology and clinical correlates

Blood Reviews

Volumn 23, Issue 4, 2009, Pages 177-189

  Blair, Price ^a   Flaumenhaft, Robert ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Granule; Endocytosis; Hemostasis; Secretion; Vesicle trafficking

Indexed keywords

PLASMA PROTEIN; SNARE PROTEIN;

ANGIOGENESIS; ANTIMICROBIAL ACTIVITY; ARTICLE; ATHEROSCLEROSIS; BLOOD CLOTTING; CELL MATURATION; CELL MEMBRANE; CELL MIGRATION; GENE MUTATION; HEMATOLOGIC MALIGNANCY; HEMOSTASIS; HOST RESISTANCE; HUMAN; IMMUNOSURVEILLANCE; INFLAMMATION; MEGAKARYOCYTE; MEMBRANE FUSION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONTENT; PROTEIN SECRETION; PROTEIN TRANSPORT; PROTEOMICS; SECRETORY GRANULE; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE FUNCTION; THROMBOCYTE RELEASE REACTION; THROMBOSIS; WOUND HEALING;

ANIMALS; ATHEROSCLEROSIS; BLOOD COAGULATION; BLOOD PLATELETS; CYTOKINES; HUMANS; IMMUNITY, INNATE; INFLAMMATION; MEGAKARYOCYTES; NEOPLASMS; NEOVASCULARIZATION, PHYSIOLOGIC; SECRETORY VESICLES; SNARE PROTEINS; WOUND HEALING;

EID: 65849360502     PISSN: 0268960X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.blre.2009.04.001     Document Type: Article

References (219)

1. Frojmovic M.M., and Milton J.G. Human platelet size, shape, and related functions in health and disease. Physiol Rev 62 (1982) 185-261
2. White J.G., and Clawson C.C. The surface-connected canalicular system of blood platelets - a fenestrated membrane system. Am J Pathol 101 (1980) 353-364
3. Harrison P., and Cramer E.M. Platelet alpha-granules. Blood Rev 7 (1993) 52-62
4. Italiano Jr. J.E., Richardson J.L., Patel-Hett S., et al. Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet alpha granules and differentially released. Blood 111 (2008) 1227-1233
5. Sehgal S., and Storrie B. Evidence that differential packaging of the major platelet granule proteins von Willebrand factor and fibrinogen can support their differential release. J Thromb Haemost 5 (2007) 2009-2016
6. Cramer E.M., Harrison P., Savidge G.F., et al. Uncoordinated expression of alpha-granule proteins in human megakaryocytes. Prog Clin Biol Res 356 (1990) 131-142
7. Hegyi E., Heilbrun L.K., and Nakeff A. Immunogold probing of platelet factor 4 in different ploidy classes of rat megakaryocytes sorted by flow cytometry. Exp Hematol 18 (1990) 789-793
8. Moebius J., Zahedi R.P., Lewandrowski U., Berger C., Walter U., and Sickmann A. The human platelet membrane proteome reveals several new potential membrane proteins. Mol Cell Proteom 4 (2005) 1754-1761
9. Li W., Rusiniak M.E., Chintala S., Gautam R., Novak E.K., and Swank R.T. Murine Hermansky-Pudlak syndrome genes: regulators of lysosome-related organelles. Bioessays 26 (2004) 616-628
10. King S.M., and Reed G.L. Development of platelet secretory granules. Semin Cell Dev Biol 13 (2002) 293-302
11. Piper R.C., and Katzmann D.J. Biogenesis and function of multivesicular bodies. Annu Rev Cell Dev Biol 23 (2007) 519-547
12. Woodman P.G., and Futter C.E. Multivesicular bodies: co-ordinated progression to maturity. Curr Opin Cell Biol 20 (2008) 408-414
13. Heijnen H.F., Debili N., Vainchencker W., Breton-Gorius J., Geuze H.J., and Sixma J.J. Multivesicular bodies are an intermediate stage in the formation of platelet alpha-granules. Blood 91 (1998) 2313-2325
14. Youssefian T., and Cramer E.M. Megakaryocyte dense granule components are sorted in multivesicular bodies. Blood 95 (2000) 4004-4007
15. Heijnen H.F., Schiel A.E., Fijnheer R., Geuze H.J., and Sixma J.J. Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules. Blood 94 (1999) 3791-3799
16. Zucker-Franklin D. Endocytosis by human platelets: metabolic and freeze-fracture studies. J Cell Biol 91 (1981) 706-715
17. Behnke O. Coated pits and vesicles transfer plasma components to platelet granules. Thromb Haemost 62 (1989) 718-722
18. Behnke O. Degrading and non-degrading pathways in fluid-phase (non-adsorptive) endocytosis in human blood platelets. J Submicrosc Cytol Pathol 24 (1992) 169-178
19. Stenberg P.E., Pestina T.I., Barrie R.J., and Jackson C.W. The Src family kinases, Fgr, Fyn, Lck, and Lyn, colocalize with coated membranes in platelets. Blood 89 (1997) 2384-2393
20. Pestina T.I., Stenberg P.E., Druker B.J., et al. Identification of the Src family kinases, Lck and Fgr in platelets. Their tyrosine phosphorylation status and subcellular distribution compared with other Src family members. Arterioscler Thromb Vasc Biol 17 (1997) 3278-3285
21. Panigada M., Porcellini S., Barbier E., et al. Constitutive endocytosis and degradation of the pre-T cell receptor. J Exp Med 195 (2002) 1585-1597
22. Heilmann E., Hynes L.A., Friese P., George I.N., Burstein S.A., and Dale G.L. Dog platelets accumulate intracellular fibrinogen as they age. J Cell Physiol 161 (1994) 23-30
23. Cramer E.M., Debili N., Martin J.F., et al. Uncoordinated expression of fibrinogen compared with thrombospondin and von Willebrand factor in maturing human megakaryocytes. Blood 73 (1989) 1123-1129
24. Koedam J.A., Cramer E.M., Briend E., Furie B., Furie B.C., and Wagner D.D. P-Selectin, a granule membrane protein of platelets and endothelial cells, follows the regulated secretory pathway in AtT-20 cells. J Cell Biol 116 (1992) 617-625
25. Daugherty B.L., Straley K.S., Sanders J.M., et al. AP-3 adaptor functions in targeting P-selectin to secretory granules in endothelial cells. Traffic 2 (2001) 406-413
26. Disdier M., Morrissey J.H., Fugate R.D., Bainton D.F., and McEver R.P. Cytoplasmic domain of P-selectin (CD62) contains the signal for sorting into the regulated secretory pathway. Mol Biol Cell 3 (1992) 309-321
27. Green S.A., Setiadi H., McEver R.P., and Kelly R.B. The cytoplasmic domain of P-selectin contains a sorting determinant that mediates rapid degradation in lysosomes. J Cell Biol 124 (1994) 435-448
28. Hartwell D.W., Mayadas T.N., Berger G., et al. Role of P-selectin cytoplasmic domain in granular targeting in vivo and in early inflammatory responses. J Cell Biol 143 (1998) 1129-1141
29. Briquet-Laugier V., Lavenu-Bombled C., Schmitt A., et al. Probing platelet factor 4 alpha-granule targeting. J Thromb Haemost 2 (2004) 2231-2240
30. El Golli N., Issertial O., Rosa J.P., and Briquet-Laugier V. Evidence for a granule targeting sequence within platelet factor 4. J Biol Chem 280 (2005) 30329-30335
31. Woulfe D.S., Lilliendahl J.K., August S., et al. Serglycin proteoglycan deletion induces defects in platelet aggregation and thrombus formation in mice. Blood 111 (2008) 3458-3467
32. Tooze S.A., Martens G.J., and Huttner W.B. Secretory granule biogenesis: rafting to the SNARE. Trends Cell Biol 11 (2001) 116-122
33. Hayward C.P., Song Z., Zheng S., et al. Multimerin processing by cells with and without pathways for regulated protein secretion. Blood 94 (1999) 1337-1347
34. Cramer E.M., Meyer D., le Menn R., and Breton-Gorius J. Eccentric localization of von Willebrand factor in an internal structure of platelet alpha-granule resembling that of Weibel-Palade bodies. Blood 66 (1985) 710-713
35. Huang R.H., Wang Y., Roth R., et al. Assembly of Weibel-Palade body-like tubules from N-terminal domains of von Willebrand factor. Proc Natl Acad Sci USA 105 (2008) 482-487
36. Blagoveshchenskaya A.D., Hannah M.J., Allen S., and Cutler D.F. Selective and signal-dependent recruitment of membrane proteins to secretory granules formed by heterologously expressed von Willebrand factor. Mol Biol Cell 13 (2002) 1582-1593
37. Wagner D.D., Saffaripour S., Bonfanti R., et al. Induction of specific storage organelles by von Willebrand factor propolypeptide. Cell 64 (1991) 403-413
38. Handagama P., Scarborough R.M., Shuman M.A., and Bainton D.F. Endocytosis of fibrinogen into megakaryocyte and platelet alpha-granules is mediated by alpha IIb beta 3 (glycoprotein IIb-IIIa). Blood 82 (1993) 135-138
39. Handagama P., Bainton D.F., Jacques Y., Conn M.T., Lazarus R.A., and Shuman M.A. Kistrin, an integrin antagonist, blocks endocytosis of fibrinogen into guinea pig megakaryocyte and platelet alpha-granules. J Clin Invest 91 (1993) 193-200
40. Handagama P.J., Amrani D.L., and Shuman M.A. Endocytosis of fibrinogen into hamster megakaryocyte alpha granules is dependent on a dimeric gamma A configuration. Blood 85 (1995) 1790-1795
41. Handagama P.J., Shuman M.A., and Bainton D.F. Incorporation of intravenously injected albumin, immunoglobulin G, and fibrinogen in guinea pig megakaryocyte granules. J Clin Invest 84 (1989) 73-82
42. Handagama P.J., George J.N., Shuman M.A., McEver R.P., and Bainton D.F. Incorporation of a circulating protein into megakaryocyte and platelet granules. Proc Natl Acad Sci USA 84 (1987) 861-865
43. George J.N., and Saucerman S. Platelet IgG, IgA, IgM, and albumin: correlation of platelet and plasma concentrations in normal subjects and in patients with ITP or dysproteinemia. Blood 72 (1988) 362-365
44. Bouchard B.A., Meisler N.T., Nesheim M.E., Liu C.X., Strickland D.K., and Tracy P.B. A unique function for LRP-1: a component of a two-receptor system mediating specific endocytosis of plasma-derived factor V by megakaryocytes. J Thromb Haemost 6 (2008) 638-644
45. Bouchard B.A., Williams J.L., Meisler N.T., Long M.W., and Tracy P.B. Endocytosis of plasma-derived factor V by megakaryocytes occurs via a clathrin-dependent, specific membrane binding event. J Thromb Haemost 3 (2005) 541-551
46. Tavassoli M. Fusion-fission reorganization of membrane: a developing membrane model for thrombocytogenesis in megakaryocytes. Blood Cells 5 (1979) 89-99
47. Italiano Jr. J.E., Lecine P., Shivdasani R.A., and Hartwig J.H. Blood platelets are assembled principally at the ends of proplatelet processes produced by differentiated megakaryocytes. J Cell Biol 147 (1999) 1299-1312
48. Patel S.R., Hartwig J.H., and Italiano Jr. J.E. The biogenesis of platelets from megakaryocyte proplatelets. J Clin Invest 115 (2005) 3348-3354
49. Handagama P., Jain N.C., Kono C.S., and Feldman B.F. Scanning electron microscopic studies of megakaryocytes and platelet formation in the dog and rat. Am J Vet Res 47 (1986) 2454-2460
50. Junt T., Schulze H., Chen Z., et al. Dynamic visualization of thrombopoiesis within bone marrow. Science 317 (2007) 1767-1770
51. Richardson J.L., Shivdasani R.A., Boers C., Hartwig J.H., and Italiano Jr. J.E. Mechanisms of organelle transport and capture along proplatelets during platelet production. Blood 106 (2005) 4066-4075
52. Nurden A.T., and Nurden P. The gray platelet syndrome: clinical spectrum of the disease. Blood Rev 21 (2007) 21-36
53. White J.G. Medich giant platelet disorder: a unique alpha granule deficiency I. Structural abnormalities. Platelets 15 (2004) 345-353
54. White J.G., Key N.S., King R.A., and Vercellotti G.M. The White platelet syndrome: a new autosomal dominant platelet disorder. Platelets 15 (2004) 173-184
55. Kimura Y., Hart A., Hirashima M., et al. Zinc finger protein, Hzf, is required for megakaryocyte development and hemostasis. J Exp Med 195 (2002) 941-952
56. Benit L., Cramer E.M., Masse J.M., Dusanter-Fourt I., and Favier R. Molecular study of the hematopoietic zinc finger gene in three unrelated families with gray platelet syndrome. J Thromb Haemost 3 (2005) 2077-2080
57. Balduini C.L., Pecci A., Loffredo G., et al. Effects of the R216Q mutation of GATA-1 on erythropoiesis and megakaryocytopoiesis. Thromb Haemost 91 (2004) 129-140
58. Tubman V.N., Levine J.E., Campagna D.R., et al. X-Linked gray platelet syndrome due to a GATA1 Arg216Gln mutation. Blood 109 (2007) 3297-3299
59. Lo B., Li L., Gissen P., et al. Requirement of VPS33B, a member of the Sec1/Munc18 protein family, in megakaryocyte and platelet alpha-granule biogenesis. Blood 106 (2005) 4159-4166
60. Gissen P., Johnson C.A., Morgan N.V., et al. Mutations in VPS33B, encoding a regulator of SNARE-dependent membrane fusion, cause arthrogryposis-renal dysfunction-cholestasis (ARC) syndrome. Nat Genet 36 (2004) 400-404
61. Detter J.C., Zhang Q., Mules E.H., et al. Rab geranylgeranyl transferase alpha mutation in the gunmetal mouse reduces Rab prenylation and platelet synthesis. Proc Natl Acad Sci USA 97 (2000) 4144-4149
62. Swank R.T., Jiang S.Y., Reddington M., et al. Inherited abnormalities in platelet organelles and platelet formation and associated altered expression of low molecular weight guanosine triphosphate-binding proteins in the mouse pigment mutant gunmetal. Blood 81 (1993) 2626-2635
63. Tiwari S., Italiano Jr. J.E., Barral D.C., et al. A role for Rab27b in NF-E2-dependent pathways of platelet formation. Blood 102 (2003) 3970-3979
64. TheBarral D.C., Ramalho J.S., Anders R., et al. Functional redundancy of Rab27 proteins and the pathogenesis of Griscelli syndrome. J Clin Invest 110 (2002) 247-257
65. Fukuda M. Versatile role of Rab27 in membrane trafficking: focus on the Rab27 effector families. J Biochem 137 (2005) 9-16
66. Karniguian A., Zahraoui A., and Tavitian A. Identification of small GTP-binding rab proteins in human platelets: thrombin-induced phosphorylation of rab3B, rab6, and rab8 proteins. Proc Natl Acad Sci USA 90 (1993) 7647-7651
67. Kruit J.K., Drayer A.L., Bloks V.W., et al. Plant sterols cause macrothrombocytopenia in a mouse model of sitosterolemia. J Biol Chem 283 (2008) 6281-6287
68. Rees D.C., Iolascon A., Carella M., et al. Stomatocytic haemolysis and macrothrombocytopenia (Mediterranean stomatocytosis/macrothrombocytopenia) is the haematological presentation of phytosterolaemia. Br J Haematol 130 (2005) 297-309
69. Flaumenhaft R. Molecular basis of platelet granule secretion. Arterioscler Thromb Vasc Biol 23 (2003) 1152-1160
70. Sudhof T.C., and Rothman J.E. Membrane fusion: grappling with SNARE and SM proteins. Science 323 (2009) 474-477
71. Lemons P.P., Chen D., Bernstein A.M., Bennett M.K., and Whiteheart S.W. Regulated secretion in platelets: identification of elements of the platelet exocytosis machinery. Blood 90 (1997) 1490-1500
72. Flaumenhaft R., Croce K., Chen E., Furie B., and Furie B.C. Proteins of the exocytotic core complex mediate platelet alpha-granule secretion. Roles of vesicle-associated membrane protein, SNAP-23, and syntaxin 4. J Biol Chem 274 (1999) 2492-2501
73. Bernstein A.M., and Whiteheart S.W. Identification of a cellubrevin/vesicle associated membrane protein 3 homologue in human platelets. Blood 93 (1999) 571-579
74. Polgar J., Chung S.H., and Reed G.L. Vesicle-associated membrane protein 3 (VAMP-3) and VAMP-8 are present in human platelets and are required for granule secretion. Blood 100 (2002) 1081-1083
75. Polgar J., Lane W.S., Chung S.H., Houng A.K., and Reed G.L. Phosphorylation of SNAP-23 in activated human platelets. J Biol Chem 278 (2003) 44369-44376
76. Ren Q., Barber H.K., Crawford G.L., et al. Endobrevin/VAMP-8 is the primary v-SNARE for the platelet release reaction. Mol Biol Cell 18 (2007) 24-33
77. Chen D., Bernstein A.M., Lemons P.P., and Whiteheart S.W. Molecular mechanisms of platelet exocytosis: role of SNAP-23 and syntaxin 2 in dense core granule release. Blood 95 Feb 1 (2000) 921-929
78. Schraw T.D., Rutledge T.W., Crawford G.L., et al. Granule stores from cellubrevin/VAMP-3 null mouse platelets exhibit normal stimulus-induced release. Blood 8 (2003) 8
79. Lemons P.P., Chen D., and Whiteheart S.W. Molecular mechanisms of platelet exocytosis: requirements for alpha-granule release. Biochem Biophys Res Commun 267 (2000) 875-880
80. Lai K.C., and Flaumenhaft R. SNARE protein degradation upon platelet activation: calpain cleaves SNAP-23. J Cell Physiol 194 (2003) 206-214
81. Feng D., Crane K., Rozenvayn N., Dvorak A.M., and Flaumenhaft R. Subcellular distribution of 3 functional SNARE proteins: Human cellubrevin, SNAP-23, and Syntaxin 2. Blood 99 (2002) 4006-4014
82. Houng A., Polgar J., and Reed G.L. Munc18-syntaxin complexes and exocytosis in human platelets. J Biol Chem 278 (2003) 19627-19633
83. Shirakawa R., Higashi T., Tabuchi A., et al. Munc13-4 is a GTP-Rab27-binding protein regulating dense core granule secretion in platelets. J Biol Chem 279 (2004) 10730-10737
84. Dent J., Kato K., Peng X.R., et al. A prototypic platelet septin and its participation in secretion. Proc Natl Acad Sci USA 99 (2002) 3064-3069
85. Whiteheart S.W., Schraw T., and Matveeva E.A. N-Ethylmaleimide sensitive factor (NSF) structure and function. Int Rev Cytol 207 (2001) 71-112
86. Polgar J., and Reed G.L. A critical role for N-ethylmaleimide-sensitive fusion protein (NSF) in platelet granule secretion. Blood 94 (1999) 1313-1318
87. Morrell C.N., Matsushita K., Chiles K., et al. Regulation of platelet granule exocytosis by S-nitrosylation. Proc Natl Acad Sci USA 102 (2005) 3782-3787
88. Clary D.O., Griff I.C., and Rothman J.E. SNAPs, a family of NSF attachment proteins involved in intracellular membrane fusion in animals and yeast. Cell 61 (1990) 709-721
89. Fitzgerald M.L., and Reed G.L. Rab6 is phosphorylated in thrombin-activated platelets by a protein kinase C-dependent mechanism: effects on GTP/GDP binding and cellular distribution. Biochem J 342 (1999) 353-360
90. Shirakawa R., Yoshioka A., Horiuchi H., Nishioka H., Tabuchi A., and Kita T. Small GTPase rab4 regulates Ca2+-induced alpha-granule secretion in platelets. J Biol Chem 275 (2000) 33844-33849
91. Zerial M., and McBride H. Rab proteins as membrane organizers. Nat Rev Mol Cell Biol 2 (2001) 107-117
92. Berger G., Masse J.M., and Cramer E.M. Alpha-granule membrane mirrors the platelet plasma membrane and contains the glycoproteins Ib, IX, and V. Blood 87 (1996) 1385-1395
93. Maynard D.M., Heijnen H.F., Horne M.K., White J.G., and Gahl W.A. Proteomic analysis of platelet alpha-granules using mass spectrometry. J Thromb Haemost 5 (2007) 1945-1955
94. Niiya K., Hodson E., Bader R., et al. Increased surface expression of the membrane glycoprotein IIb/IIIa complex induced by platelet activation. Relationship to the binding of fibrinogen and platelet aggregation. Blood 70 (1987) 475-483
95. Berger G., Caen J.P., Berndt M.C., and Cramer E.M. Ultrastructural demonstration of CD36 in the alpha-granule membrane of human platelets and megakaryocytes. Blood 82 (1993) 3034-3044
96. Nurden P., Jandrot-Perrus M., Combrie R., et al. Severe deficiency of glycoprotein VI in a patient with gray platelet syndrome. Blood 104 (2004) 107-114
97. Suzuki H., Murasaki K., Kodama K., and Takayama H. Intracellular localization of glycoprotein VI in human platelets and its surface expression upon activation. Br J Haematol 121 (2003) 904-912
98. Piersma S.R., Broxterman H.J., Kapci M., et al. Proteomics of the TRAP-induced platelet releasate. J Proteom (2008)
99. Hernandez-Ruiz L., Valverde F., Jimenez-Nunez M.D., et al. Organellar proteomics of human platelet dense granules reveals that 14-3-3zeta is a granule protein related to atherosclerosis. J Proteom Res 6 (2007) 4449-4457
100. Coppinger J.A., Cagney G., Toomey S., et al. Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions. Blood 103 (2004) 2096-2104
101. Coppinger J.A., O'Connor R., Wynne K., et al. Moderation of the platelet releasate response by aspirin. Blood 109 (2007) 4786-4792
102. Cramer E.M., Breton-Gorius J., Beesley J.E., and Martin J.F. Ultrastructural demonstration of tubular inclusions coinciding with von Willebrand factor in pig megakaryocytes. Blood 71 (1988) 1533-1538
103. Gralnick H.R., Williams S.B., McKeown L.P., Krizek D.M., Shafer B.C., and Rick M.E. Platelet von Willebrand factor: comparison with plasma von Willebrand factor. Thromb Res 38 (1985) 623-633
104. Bowie E.J., Solberg Jr. L.A., Fass D.N., et al. Transplantation of normal bone marrow into a pig with severe von Willebrand's disease. J Clin Invest 78 (1986) 26-30
105. De Meyer S.F., Vandeputte N., Pareyn I., et al. Restoration of plasma von Willebrand factor deficiency is sufficient to correct thrombus formation after gene therapy for severe von Willebrand disease. Arterioscler Thromb Vasc Biol (2008)
106. Rendu F., and Brohard-Bohn B. The platelet release reaction: granules' constituents, secretion and functions. Platelets 12 (2001) 261-273
107. Hayward C.P., Furmaniak-Kazmierczak E., Cieutat A.M., et al. Factor V is complexed with multimerin in resting platelet lysates and colocalizes with multimerin in platelet alpha-granules. J Biol Chem 270 (1995) 19217-19224
108. Jeimy S.B., Fuller N., Tasneem S., et al. Multimerin 1 binds factor V and activated factor V with high affinity and inhibits thrombin generation. Thromb Haemost 100 (2008) 1058-1067
109. Kiesselbach T.H., and Wagner R.H. Demonstration of factor XIII in human megakaryocytes by a fluorescent antibody technique. Ann NY Acad Sci 202 (1972) 318-328
110. Monkovic D.D., and Tracy P.B. Functional characterization of human platelet-released factor V and its activation by factor Xa and thrombin. J Biol Chem 265 (1990) 17132-17140
111. Gould W.R., Silveira J.R., and Tracy P.B. Unique in vivo modifications of coagulation factor V produce a physically and functionally distinct platelet-derived cofactor: characterization of purified platelet-derived factor V/Va. J Biol Chem 279 (2004) 2383-2393
112. Hu C.J., Baglia F.A., Mills D.C., Konkle B.A., and Walsh P.N. Tissue-specific expression of functional platelet factor XI is independent of plasma factor XI expression. Blood 91 (1998) 3800-3807
113. Veljkovic D.K., Rivard G.E., Diamandis M., Blavignac J., Cramer-Borde E.M., and Hayward C.P. Increased expression of urokinase plasminogen activator in Quebec platelet disorder is linked to megakaryocyte differentiation. Blood 113 (2009) 1535-1542
114. Hayward C.P., Cramer E.M., Kane W.H., et al. Studies of a second family with the Quebec platelet disorder: evidence that the degradation of the alpha-granule membrane and its soluble contents are not secondary to a defect in targeting proteins to alpha-granules. Blood 89 (1997) 1243-1253
115. Novotny W.F., Girard T.J., Miletich J.P., and Broze Jr. G.J. Platelets secrete a coagulation inhibitor functionally and antigenically similar to the lipoprotein associated coagulation inhibitor. Blood 72 (1988) 2020-2025
116. Schwarz H.P., Heeb M.J., Wencel-Drake J.D., and Griffin J.H. Identification and quantitation of protein S in human platelets. Blood 66 (1985) 1452-1455
117. Van Nostrand W.E., Schmaier A.H., Farrow J.S., and Cunningham D.D. Protease nexin-II (amyloid beta-protein precursor): a platelet alpha-granule protein. Science 248 (1990) 745-748
118. Xu F., Previti M.L., and Van Nostrand W.E. Increased severity of hemorrhage in transgenic mice expressing cerebral protease nexin-2/amyloid beta-protein precursor. Stroke 38 (2007) 2598-2601
119. May A.E., Seizer P., and Gawaz M. Platelets: inflammatory firebugs of vascular walls. Arterioscler Thromb Vasc Biol 28 (2008) s5-s10
120. Bombeli T., Schwartz B.R., and Harlan J.M. Adhesion of activated platelets to endothelial cells: evidence for a GPIIbIIIa-dependent bridging mechanism and novel roles for endothelial intercellular adhesion molecule 1 (ICAM-1), alphavbeta3 integrin, and GPIbalpha. J Exp Med 187 (1998) 329-339
121. von Hundelshausen P., and Weber C. Platelets as immune cells: bridging inflammation and cardiovascular disease. Circ Res 100 (2007) 27-40
122. Larsen E., Celi A., Gilbert G.E., et al. PADGEM protein: a receptor that mediates the interaction of activated platelets with neutrophils and monocytes. Cell 59 (1989) 305-312
123. Diacovo T.G., Puri K.D., Warnock R.A., Springer T.A., and von Andrian U.H. Platelet-mediated lymphocyte delivery to high endothelial venules. Science 273 (1996) 252-255
124. Frenette P.S., Johnson R.C., Hynes R.O., and Wagner D.D. Platelets roll on stimulated endothelium in vivo: an interaction mediated by endothelial P-selectin. Proc Natl Acad Sci USA 92 (1995) 7450-7454
125. Massberg S., Enders G., Leiderer R., et al. Platelet-endothelial cell interactions during ischemia/reperfusion: the role of P-selectin. Blood 92 (1998) 507-515
126. Romo G.M., Dong J.F., Schade A.J., et al. The glycoprotein Ib-IX-V complex is a platelet counterreceptor for P-selectin. J Exp Med 190 (1999) 803-814
127. Gawaz M., Langer H., and May A.E. Platelets in inflammation and atherogenesis. J Clin Invest 115 (2005) 3378-3384
128. Braun O.O., Slotta J.E., Menger M.D., Erlinge D., and Thorlacius H. Primary and secondary capture of platelets onto inflamed femoral artery endothelium is dependent on P-selectin and PSGL-1. Eur J Pharmacol 592 (2008) 128-132
129. Ott I., Neumann F.J., Gawaz M., Schmitt M., and Schomig A. Increased neutrophil-platelet adhesion in patients with unstable angina. Circulation 94 (1996) 1239-1246
130. Diacovo T.G., Roth S.J., Buccola J.M., Bainton D.F., and Springer T.A. Neutrophil rolling, arrest, and transmigration across activated, surface-adherent platelets via sequential action of P-selectin and the beta 2-integrin CD11b/CD18. Blood 88 (1996) 146-157
131. Tabuchi A., and Kuebler W.M. Endothelium-platelet interactions in inflammatory lung disease. Vasc Pharmacol 49 (2008) 141-150
132. Zarbock A., Singbartl K., and Ley K. Complete reversal of acid-induced acute lung injury by blocking of platelet-neutrophil aggregation. J Clin Invest 116 (2006) 3211-3219
133. Gleissner C.A., von Hundelshausen P., and Ley K. Platelet chemokines in vascular disease. Arterioscler Thromb Vasc Biol 28 (2008) 1920-1927
134. Brandt E., Petersen F., Ludwig A., Ehlert J.E., Bock L., and Flad H.D. The beta-thromboglobulins and platelet factor 4: blood platelet-derived CXC chemokines with divergent roles in early neutrophil regulation. J Leukocyte Biol 67 (2000) 471-478
135. Slungaard A. Platelet factor 4: a chemokine enigma. Int J Biochem Cell Biol 37 (2005) 1162-1167
136. Zucker M.B., and Katz I.R. Platelet factor 4: production, structure, and physiologic and immunologic action. Proc Soc Exp Biol Med 198 (1991) 693-702
137. Kasper B., Brandt E., Bulfone-Paus S., and Petersen F. Platelet factor 4 (PF-4)-induced neutrophil adhesion is controlled by src-kinases, whereas PF-4-mediated exocytosis requires the additional activation of p38 MAP kinase and phosphatidylinositol 3-kinase. Blood 103 (2004) 1602-1610
138. Kasper B., Brandt E., Brandau S., and Petersen F. Platelet factor 4 (CXC chemokine ligand 4) differentially regulates respiratory burst, survival, and cytokine expression of human monocytes by using distinct signaling pathways. J Immunol 179 (2007) 2584-2591
139. Scheuerer B., Ernst M., Durrbaum-Landmann I., et al. The CXC-chemokine platelet factor 4 promotes monocyte survival and induces monocyte differentiation into macrophages. Blood 95 (2000) 1158-1166
140. von Hundelshausen P., Koenen R.R., Sack M., et al. Heterophilic interactions of platelet factor 4 and RANTES promote monocyte arrest on endothelium. Blood 105 (2005) 924-930
141. Walz A., Dewald B., von Tscharner V., and Baggiolini M. Effects of the neutrophil-activating peptide NAP-2, platelet basic protein, connective tissue-activating peptide III and platelet factor 4 on human neutrophils. J Exp Med 170 (1989) 1745-1750
142. Schenk B.I., Petersen F., Flad H.D., and Brandt E. Platelet-derived chemokines CXC chemokine ligand (CXCL)7, connective tissue-activating peptide III, and CXCL4 differentially affect and cross-regulate neutrophil adhesion and transendothelial migration. J Immunol 169 (2002) 2602-2610
143. Libby P. Atherosclerosis: disease biology affecting the coronary vasculature. Am J Cardiol 98 (2006) 3Q-9Q
144. Croce K., and Libby P. Intertwining of thrombosis and inflammation in atherosclerosis. Curr Opin Hematol 14 (2007) 55-61
145. Collins R.G., Velji R., Guevara N.V., Hicks M.J., Chan L., and Beaudet A.L. P-Selectin or intercellular adhesion molecule (ICAM)-1 deficiency substantially protects against atherosclerosis in apolipoprotein E-deficient mice. J Exp Med 191 (2000) 189-194
146. Dong Z.M., Brown A.A., and Wagner D.D. Prominent role of P-selectin in the development of advanced atherosclerosis in ApoE-deficient mice. Circulation 101 (2000) 2290-2295
147. Burger P.C., and Wagner D.D. Platelet P-selectin facilitates atherosclerotic lesion development. Blood 101 (2003) 2661-2666
148. Wang K., Zhou X., Zhou Z., et al. Platelet, not endothelial, P-selectin is required for neointimal formation after vascular injury. Arterioscler Thromb Vasc Biol 25 (2005) 1584-1589
149. Huo Y., Schober A., Forlow S.B., et al. Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. Nat Med 9 (2003) 61-67
150. Schober A., Manka D., von Hundelshausen P., et al. Deposition of platelet RANTES triggering monocyte recruitment requires P-selectin and is involved in neointima formation after arterial injury. Circulation 106 (2002) 1523-1529
151. Koenen R.R., von Hundelshausen P., Nesmelova I.V., et al. Disrupting functional interactions between platelet chemokines inhibits atherosclerosis in hyperlipidemic mice. Nat Med 15 (2009) 97-103
152. -/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 394 (1998) 894-897
153. Hayes I.M., Jordan N.J., Towers S., et al. Human vascular smooth muscle cells express receptors for CC chemokines. Arterioscler Thromb Vasc Biol 18 (1998) 397-403
154. -/- mice. Thromb Haemost 98 (2007) 1108-1113
155. Karshovska E., Zernecke A., Sevilmis G., et al. Expression of HIF-1alpha in injured arteries controls SDF-1alpha mediated neointima formation in apolipoprotein E deficient mice. Arterioscler Thromb Vasc Biol 27 (2007) 2540-2547
156. Tiedt R., Schomber T., Hao-Shen H., and Skoda R.C. Pf4-Cre transgenic mice allow the generation of lineage-restricted gene knockouts for studying megakaryocyte and platelet function in vivo. Blood 109 (2007) 1503-1506
157. Scheld W.M., Valone J.A., and Sande M.A. Bacterial adherence in the pathogenesis of endocarditis. Interaction of bacterial dextran, platelets, and fibrin. J Clin Invest 61 (1978) 1394-1404
158. Klinger M.H., and Jelkmann W. Role of blood platelets in infection and inflammation. J Interferon Cytokine Res 22 (2002) 913-922
159. Durack D.T. Experimental bacterial endocarditis. IV. Structure and evolution of very early lesions. J Pathol 115 (1975) 81-89
160. Sullam P.M., Drake T.A., and Sande M.A. Pathogenesis of endocarditis. Am J Med 78 (1985) 110-115
161. Vinter D.W., Burkel W.E., Wakefield T.W., et al. Radioisotope-labeled platelet studies and infection of vascular grafts. J Vasc Surg 1 (1984) 921
162. Zucker-Franklin D., Seremetis S., and Zheng Z.Y. Internalization of human immunodeficiency virus type I and other retroviruses by megakaryocytes and platelets. Blood 75 (1990) 1920-1923
163. Bik T., Sarov I., and Livne A. Interaction between vaccinia virus and human blood platelets. Blood 59 (1982) 482-487
164. Clawson C.C., Rao G.H., and White J.G. Platelet interaction with bacteria. IV. Stimulation of the release reaction. Am J Pathol 81 (1975) 411-420
165. Maisch P.A., and Calderone R.A. Adherence of Candida albicans to a fibrin-platelet matrix formed in vitro. Infect Immun 27 (1980) 650-656
166. McMorran B.J., Marshall V.M., de Graaf C., et al. Platelets kill intraerythrocytic malarial parasites and mediate survival to infection. Science 323 (2009) 797-800
167. Cole A.M., Ganz T., Liese A.M., Burdick M.D., Liu L., and Strieter R.M. Cutting edge: IFN-inducible ELR-CXC chemokines display defensin-like antimicrobial activity. J Immunol 167 (2001) 623-627
168. Tang Y.Q., Yeaman M.R., and Selsted M.E. Antimicrobial peptides from human platelets. Infect Immun 70 (2002) 6524-6533
169. Krijgsveld J., Zaat S.A., Meeldijk J., et al. Thrombocidins, microbicidal proteins from human blood platelets, are C-terminal deletion products of CXC chemokines. J Biol Chem 275 (2000) 20374-20381
170. Kupferwasser L.I., Yeaman M.R., Shapiro S.M., Nast C.C., and Bayer A.S. In vitro susceptibility to thrombin-induced platelet microbicidal protein is associated with reduced disease progression and complication rates in experimental Staphylococcus aureus endocarditis: microbiological, histopathologic, and echocardiographic analyses. Circulation 105 (2002) 746-752
171. Sullam P.M., Bayer A.S., Foss W.M., and Cheung A.L. Diminished platelet binding in vitro by Staphylococcus aureus is associated with reduced virulence in a rabbit model of infective endocarditis. Infect Immun 64 (1996) 4915-4921
172. Dhawan V.K., Yeaman M.R., Cheung A.L., Kim E., Sullam P.M., and Bayer A.S. Phenotypic resistance to thrombin-induced platelet microbicidal protein in vitro is correlated with enhanced virulence in experimental endocarditis due to Staphylococcus aureus. Infect Immun 65 (1997) 3293-3299
173. Mercier R.C., Rybak M.J., Bayer A.S., and Yeaman M.R. Influence of platelets and platelet microbicidal protein susceptibility on the fate of Staphylococcus aureus in an in vitro model of infective endocarditis. Infect Immun 68 (2000) 4699-4705
174. Del Conde I., Cruz M.A., Zhang H., Lopez J.A., and Afshar-Kharghan V. Platelet activation leads to activation and propagation of the complement system. J Exp Med 201 (2005) 871-879
175. Schmaier A.H., Smith P.M., and Colman R.W. Platelet C1-inhibitor. A secreted alpha-granule protein. J Clin Invest 75 (1985) 242-250
176. Devine D.V., and Rosse W.F. Regulation of the activity of platelet-bound C3 convertase of the alternative pathway of complement by platelet factor H. Proc Natl Acad Sci USA 84 (1987) 5873-5877
177. Knighton D.R., Hunt T.K., Thakral K.K., and Goodson III W.H. Role of platelets and fibrin in the healing sequence. an in vivo study of angiogenesis and collagen synthesis. Ann Surg 196 (1982) 379-388
178. Pipili-Synetos E., Papadimitriou E., and Maragoudakis M.E. Evidence that platelets promote tube formation by endothelial cells on matrigel. Br J Pharmacol 125 (1998) 1252-1257
179. Kisucka J., Butterfield C.E., Duda D.G., et al. Platelets and platelet adhesion support angiogenesis while preventing excessive hemorrhage. Proc Natl Acad Sci USA 103 (2006) 855-860
180. Nurden A.T., Nurden P., Sanchez M., Andia I., and Anitua E. Platelets and wound healing. Front Biosci 13 (2008) 3532-3548
181. Weltermann A., Wolzt M., Petersmann K., et al. Large amounts of vascular endothelial growth factor at the site of hemostatic plug formation in vivo. Arterioscler Thromb Vasc Biol 19 (1999) 1757-1760
182. Arisato T., Hashiguchi T., Sarker K.P., et al. Highly accumulated platelet vascular endothelial growth factor in coagulant thrombotic region. J Thromb Haemost 1 (2003) 2589-2593
183. Pintucci G., Froum S., Pinnell J., Mignatti P., Rafii S., and Green D. Trophic effects of platelets on cultured endothelial cells are mediated by platelet-associated fibroblast growth factor-2 (FGF-2) and vascular endothelial growth factor (VEGF). Thromb Haemost 88 (2002) 834-842
184. Brill A., Elinav H., and Varon D. Differential role of platelet granular mediators in angiogenesis. Cardiovasc Res 63 (2004) 226-235
185. Massberg S., Konrad I., Schurzinger K., et al. Platelets secrete stromal cell-derived factor 1alpha and recruit bone marrow-derived progenitor cells to arterial thrombi in vivo. J Exp Med 203 (2006) 1221-1233
186. Jimenez B., Volpert O.V., Crawford S.E., Febbraio M., Silverstein R.L., and Bouck N. Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1. Nat Med 6 (2000) 41-48
187. Bikfalvi A. Recent developments in the inhibition of angiogenesis: examples from studies on platelet factor-4 and the VEGF/VEGFR system. Biochem Pharmacol 68 (2004) 1017-1021
188. Perollet C., Han Z.C., Savona C., Caen J.P., and Bikfalvi A. Platelet factor 4 modulates fibroblast growth factor 2 (FGF-2) activity and inhibits FGF-2 dimerization. Blood 91 (1998) 3289-3299
189. Ma L., Perini R., McKnight W., et al. Proteinase-activated receptors 1 and 4 counter-regulate endostatin and VEGF release from human platelets. Proc Natl Acad Sci USA 102 (2005) 216-220
190. Kark L.R., Karp J.M., and Davies J.E. Platelet releasate increases the proliferation and migration of bone marrow-derived cells cultured under osteogenic conditions. Clin Oral Implant Res 17 (2006) 321-327
191. Anitua E., Andia I., Sanchez M., et al. Autologous preparations rich in growth factors promote proliferation and induce VEGF and HGF production by human tendon cells in culture. J Orthop Res 23 (2005) 281-286
192. Nagai M., Sato S., Kamoi H., and Kamoi K. Effects of application of platelet releasate in periodontal regeneration therapy. Int J Periodont Restorat Dent 25 (2005) 571-583
193. Moulin V., Lawny F., Barritault D., and Caruelle J.P. Platelet releasate treatment improves skin healing in diabetic rats through endogenous growth factor secretion. Cell Mol Biol (Noisy-le-grand) 44 (1998) 961-971
194. Knighton D.R., Ciresi K.F., Fiegel V.D., Austin L.L., and Butler E.L. Classification and treatment of chronic nonhealing wounds. Successful treatment with autologous platelet-derived wound healing factors (PDWHF). Ann Surg 204 (1986) 322-330
195. Steed D.L., Goslen J.B., Holloway G.A., Malone J.M., Bunt T.J., and Webster M.W. Randomized prospective double-blind trial in healing chronic diabetic foot ulcers. CT-102 activated platelet supernatant, topical versus placebo. Diabet Care 15 (1992) 1598-1604
196. Margolis D.J., Kantor J., Santanna J., Strom B.L., and Berlin J.A. Effectiveness of platelet releasate for the treatment of diabetic neuropathic foot ulcers. Diabet Care 24 (2001) 483-488
197. Josifova D., Gatt G., Aquilina A., Serafimov V., Vella A., and Felice A. Treatment of leg ulcers with platelet-derived wound healing factor (PDWHFS) in a patient with beta thalassaemia intermedia. Br J Haematol 112 (2001) 527-529
198. Herouy Y., Mellios P., Bandemir E., et al. Autologous platelet-derived wound healing factor promotes angiogenesis via alphavbeta3-integrin expression in chronic wounds. Int J Mol Med 6 (2000) 515-519
199. Senet P., Bon F.X., Benbunan M., et al. Randomized trial and local biological effect of autologous platelets used as adjuvant therapy for chronic venous leg ulcers. J Vasc Surg 38 (2003) 1342-1348
200. Ho-Tin-Noe B., Goerge T., Cifuni S.M., Duerschmied D., and Wagner D.D. Platelet granule secretion continuously prevents intratumor hemorrhage. Cancer Res 68 (2008) 6851-6858
201. Klement G.L., Yip T.T., Cassiola F., et al. Platelets actively sequester angiogenesis regulators. Blood (2008)
202. Patruno R., Arpaia N., Gadaleta C.D., et al. VEGF concentration from plasma activated platelets rich correlates with microvascular density and grading in canine mast cell tumour spontaneous model. J Cell Mol Med (2008)
203. Caine G.J., Ryan P., Lip G.Y., and Blann A.D. Significant decrease in angiopoietin-1 and angiopoietin-2 after radical prostatectomy in prostate cancer patients. Cancer Lett 251 (2007) 296-301
204. George D.J., Regan M.M., Oh W.K., et al. Radical prostatectomy lowers plasma vascular endothelial growth factor levels in patients with prostate cancer. Urology 63 (2004) 327-332
205. Salgado R., Vermeulen P.B., Van Marck E., Benoy I., and Dirix L. Correspondence re: George ML et al. Correlation of plasma and serum vascular endothelial growth factor levels with platelet count in colorectal cancer: clinical evidence of platelet scavenging? Clin Cancer Res, 6: 3147-52, 2000. Clin Cancer Res 7 (2001) 1481-1483
206. Adams J., Carder P.J., Downey S., et al. Vascular endothelial growth factor (VEGF) in breast cancer: comparison of plasma, serum, and tissue VEGF and microvessel density and effects of tamoxifen. Cancer Res 60 (2000) 2898-2905
207. Caine G.J., Lip G.Y., and Blann A.D. Platelet-derived VEGF, Flt-1, angiopoietin-1 and P-selectin in breast and prostate cancer: further evidence for a role of platelets in tumour angiogenesis. Ann Med. 36 (2004) 273-277
208. Salven P., Orpana A., and Joensuu H. Leukocytes and platelets of patients with cancer contain high levels of vascular endothelial growth factor. Clin Cancer Res 5 (1999) 487-491
209. Gunsilius E., Petzer A., Stockhammer G., et al. Thrombocytes are the major source for soluble vascular endothelial growth factor in peripheral blood. Oncology 58 (2000) 169-174
210. Gasic G.J., Gasic T.B., and Stewart C.C. Antimetastatic effects associated with platelet reduction. Proc Natl Acad Sci USA 61 (1968) 46-52
211. Pearlstein E., Ambrogio C., and Karpatkin S. Effect of antiplatelet antibody on the development of pulmonary metastases following injection of CT26 colon adenocarcinoma, Lewis lung carcinoma, and B16 amelanotic melanoma tumor cells into mice. Cancer Res 44 (1984) 3884-3887
212. Skolnik G., Ericson L.E., and Bagge U. The effect of thrombocytopenia and antiserotonin treatment on the lodgement of circulating tumor cells. A vital fluorescence microscopic, electron microscopic and isotope study in the rat. J Cancer Res Clin Oncol 105 (1983) 30-37
213. Jain S., Zuka M., Liu J., et al. Platelet glycoprotein Ib alpha supports experimental lung metastasis. Proc Natl Acad Sci USA 104 (2007) 9024-9028
214. Karpatkin S., and Pearlstein E. Role of platelets in tumor cell metastases. Ann Int Med 95 (1981) 636-641
215. Nash G.F., Turner L.F., Scully M.F., and Kakkar A.K. Platelets and cancer. Lancet Oncol 3 (2002) 425-430
216. Borsig L., Wong R., Feramisco J., Nadeau D.R., Varki N.M., and Varki A. Heparin and cancer revisited: mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis. Proc Natl Acad Sci USA 98 (2001) 3352-3357
217. Kim Y.J., Borsig L., Varki N.M., and Varki A. P-Selectin deficiency attenuates tumor growth and metastasis. Proc Natl Acad Sci USA 95 (1998) 9325-9330
218. Lawler K., Meade G., O'Sullivan G., and Kenny D. Shear stress modulates the interaction of platelet-secreted matrix proteins with tumor cells through the integrin alphavbeta3. Am J Physiol Cell Physiol 287 (2004) C1320-C1327
219. Belloc C., Lu H., Soria C., Fridman R., Legrand Y., and Menashi S. The effect of platelets on invasiveness and protease production of human mammary tumor cells. Int J Cancer 60 (1995) 413-417